CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Net sales	$ 1,040	$ 883	$ 3,128	$ 2,263
Cost of products sold	471	451	1,385	1,174
Gross profit	569	432	1,743	1,089
Selling, general, and administrative expenses	395	313	1,174	929
Research and development expenses	39	29	122	85
Goodwill impairment	0	0	0	157
Provisions	3	18	11	62
Operating income (loss)	132	72	436	(144)
Other income and expenses:
Interest expense, net	14	14	43	31
Other expense (income), net	5	1	4	4
Income (loss) before income taxes	113	57	389	(179)
Provision (benefit) for income taxes	29	9	97	(1)
Net income (loss)	84	48	292	(178)
Less: Net income attributable to noncontrolling interest	0	1	0	0
Net income (loss) attributable to Dentsply Sirona	$ 84	$ 47	$ 292	$ (178)
Net income (loss) per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ 0.39	$ 0.22	$ 1.34	$ (0.81)
Diluted (in dollars per share)	$ 0.38	$ 0.22	$ 1.32	$ (0.81)
Weighted average common shares outstanding:
Basic (in shares)	218.6	218.5	218.6	219.4
Diluted (in shares)	220.5	219.2	220.7	219.4